🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
ABBV
NYSE
🇺🇸 US
AbbVie Inc.
Pharmaceuticals
16Score
DipBuster Score™
$284.72
$4.36 (0%)
Live price · Source: FMP-live
52-Week Position
$190.75
93% of range
$291.40
Dividend
—
no income
Mkt Cap
$503.13B
total value
Mkt Cap$503.13B
P/EN/A
DividendNone
BetaN/A
52W High$291.40
52W Low$190.75
DipBuster Brief
Key signals at a glance
Zone: Sell / Avoid
Bearish
Near 52-Week High — Asymmetric Risk
At 93% of its annual range the stock is close to its peak. New buyers face limited upside and meaningful downside if sentiment shifts.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt Cap$503.13B
52W Position93% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at AbbVie Inc. (ABBV), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-09-30 | Quaggin Susan E | BUY | 59 |
| 2026-09-30 | Rapp Edward J | BUY | 129 |
| 2026-08-14 | Donoghoe Nicholas | SELL | 32,710 |
| 2026-08-14 | Donoghoe Nicholas | SELL | 32,710 |
| 2026-08-14 | Donoghoe Nicholas | BUY | 32,710 |
| 2026-06-30 | Quaggin Susan E | BUY | 62 |
| 2026-06-30 | Rapp Edward J | BUY | 134 |
| 2026-05-08 | Quaggin Susan E | BUY | 1,118 |
| 2026-05-08 | Davis Jennifer L. | BUY | 1,118 |
| 2026-05-08 | Meyer Melody B | BUY | 1,118 |
Valuation
P/E RatioN/A
Market Cap$503.13B
BetaN/A
Dividend/yrNone
52W High$291.40
52W Low$190.75
52-Week Range
$190.75Now$291.40
93% through annual range
From 52W High−2.3%
From 52W Low+49.3%
📖 Plain English Summary
AbbVie Inc. is at 93% of its 52-week range.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for ABBV
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — ABBV
Heuristic · balance sheet, insider filings, price data, academic research
AbbVie Inc. — DipBuster Score 16/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track AbbVie Inc. free
Add ABBV to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
3/25
Momentum & Volume
8/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
0
/100 · NEUTRAL
dip depth
0/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 16/100
📊
Run a full check in the AI analysis tab for a deeper look.